Silver Book Fact

Major cardiovascular event rates could be reduced by 80% simply by acting on known risk factors with therapies already shown to be effective.

Califf R, Harrington R, Madre L, Peterson E, et al. Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics. Health Affairs. 2007; 26(1): 62-74. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.26.1.62

Reference

Title
Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Califf R, Harrington R, Madre L, Peterson E, et al.
Volume & Issue
Volume 26, Issue 1
Pages
62-74
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Adjusted-dose warfarin reduced stroke risk in AFib patients
    Meta-analysis of randomized trials found that adjusted-dose warfarin reduced stroke risk in atrial fibrillation patients by 60%. Antiplatelet agents reduced risk by 20%.  
  • Compared to predicted levels in the absence of drug therapy, there were 9% fewer deaths from major cardiovascular disease in 2001 and 38% and 25% fewer hospital discharges for stroke…  
  • Following the current path, pulmonary condition cases will increase by 31.3% between 2003 and 2023. If an alternative path is taken, there will be 9.1% fewer pulmonary condition cases.  
  • Death rates from heart disease have decreased from 586.6 deaths per 100,000 persons in 1950, to 240.8 deaths per 100,000 persons in 2002.  
  • The development of antioxidants that reduce oxidative damage is underway. One antioxidant that has been found, uric acid, has an even greater protective effect when combined with tPA.